Pharmaron Beijing , Ltd.'s goodwill is $3.5B.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
As of the most recent data (June 2026), 3759.HK shows a goodwill of $3.5B. That compares with $3B in the prior-year period — up 17.5% year over year. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, 3759.HK's goodwill is now $3.5B (was $3B) — a 17.5% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Pharmaron Beijing , Ltd. is outperforming or lagging.
Tracking 3759.HK's goodwill over time shows whether Pharmaron Beijing , Ltd. is scaling, shrinking, or reshaping that part of the business. The current reading is $3.5B That compares with $3B in the prior-year period — up 17.5% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this goodwill page, Stockcircle has Pharmaron Beijing , Ltd.'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect goodwill (currently $3.5B) with ownership activity and broader fundamentals.
Pharmaron Beijing , Ltd.'s goodwill is $3.5B; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.